Patents by Inventor Se-In Chang

Se-In Chang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250039410
    Abstract: Provided is a transform coefficient scan method including: determining a reference transform block for a decoding target block; deriving a scanning map of the decoding target block using scanning information of the reference transform block; and performing inverse scanning on a transform coefficient of the decoding target block using the derived scanning map. According to the present invention, picture encoding/decoding efficiency may be improved.
    Type: Application
    Filed: October 17, 2024
    Publication date: January 30, 2025
    Inventors: Sung Chang LIM, Hui Yong KIM, Se Yoon JEONG, Jong Ho KIM, Ha Hyun LEE, Jin Ho LEE, Jin Soo CHOI, Jin Woong KIM
  • Publication number: 20250039422
    Abstract: An inter prediction method according to the present invention comprises the steps of: selecting candidate units from among reconstructed neighbor units; creating a candidate unit set with respect to units to be decoded, using the selected candidate units; determining a reference unit from among the candidate units which constitute the created candidate unit set; and performing inter prediction on the units to be decoded, using the determined reference unit. According to the present invention, image encoding/decoding efficiency can be improved.
    Type: Application
    Filed: October 15, 2024
    Publication date: January 30, 2025
    Applicant: Electronics and Telecommunications Research Institute
    Inventors: Sung Chang LIM, Hui Yong KIM, Se Yoon JEONG, Suk Hee CHO, Jong Ho KIM, Ha Hyun LEE, Jin Ho LEE, Jin Soo CHOI, Jin Woong KIM, Chie Teuk AHN
  • Publication number: 20250039406
    Abstract: An intra prediction method according to the present invention comprises the following steps: performing a directional prediction using at least one of a neighboring pixel of a current block and a left upper corner pixel positioned at a left upper corner of the current block so as to obtain a first prediction value for the current block; obtaining a second prediction value for the current block using the reference sample positioned in the current block; and weighted summing the first prediction value and the second prediction value using a weighting matrix so as to obtain a final prediction value for the current block. According to the present invention, image encoding/decoding efficiency may be improved.
    Type: Application
    Filed: October 15, 2024
    Publication date: January 30, 2025
    Applicant: Electronics and Telecommunications Research Institute
    Inventors: Jin Ho LEE, Hui Yong KIM, Sung Chang LIM, Jong Ho KIM, Ha Hyun LEE, Se Yoon JEONG, Suk Hee CHO, Jin Soo CHOI, Jin Woong KIM, Chie Teuk AHN
  • Patent number: 12212739
    Abstract: Provided are an image encoding method and device. When carrying out image encoding for a block within a slice, at least one block in a restored block of the slice is set as a reference block. When this is done, the encoding parameters of the reference block are distinguished, and the block to be encoded is encoded adaptively based on the encoding parameters.
    Type: Grant
    Filed: September 27, 2023
    Date of Patent: January 28, 2025
    Assignee: Electronics and Telecommunications Research Institute
    Inventors: Sung Chang Lim, Jong Ho Kim, Hae Chul Choi, Hui Yong Kim, Ha Hyun Lee, Jin Ho Lee, Se Yoon Jeong, Suk Hee Cho, Jin Soo Choi, Jin Woo Hong, Jin Woong Kim
  • Patent number: 12206843
    Abstract: Provided are an image encoding method and device. When carrying out image encoding for a block within a slice, at least one block in a restored block of the slice is set as a reference block. When this is done, the encoding parameters of the reference block are distinguished, and the block to be encoded is encoded adaptively based on the encoding parameters.
    Type: Grant
    Filed: September 27, 2023
    Date of Patent: January 21, 2025
    Assignee: Electronics and Telecommunications Research Institute
    Inventors: Sung Chang Lim, Jong Ho Kim, Hae Chul Choi, Hui Yong Kim, Ha Hyun Lee, Jin Ho Lee, Se Yoon Jeong, Suk Hee Cho, Jin Soo Choi, Jin Woo Hong, Jin Woong Kim
  • Publication number: 20250024073
    Abstract: Provided is a method for performing intra-prediction, using an adaptive filter. The method for performing intra-prediction includes the steps of: determining whether or not to apply a first filter for a reference pixel value on the basis of information of a neighboring block of a current block; applying the first filter for the reference pixel value when it is determined to apply to the first filter; performing intra-prediction on the current block on the basis of the reference pixel value; determining whether or not to apply a second filter for a prediction value according to each prediction mode of the current block, which is predicted by the intra-prediction performance on the basis of the information of the neighboring blocks; and applying the second filter for the prediction value according to each prediction mode of the current block when it is determined to apply to the second filter.
    Type: Application
    Filed: July 26, 2024
    Publication date: January 16, 2025
    Applicant: Electronics and Telecommunications Research Institute
    Inventors: Jin Ho LEE, Hui Yong KIM, Se Yoon JEONG, Suk Hee CHO, Ha Hyun LEE, Jong Ho KIM, Sung Chang LIM, Jin Soo CHOI, Jin Woong KIM, Chie Teuk AHN
  • Patent number: 12139455
    Abstract: Polyethylene glycol derivatives of the following formula I and uses thereof are disclosed. A method for manufacturing the polyethylene glycol derivatives is also disclosed.
    Type: Grant
    Filed: December 20, 2022
    Date of Patent: November 12, 2024
    Assignee: HANMI PHARM. CO., LTD.
    Inventors: Dae Jin Kim, Jong Soo Lee, Sung Min Bae, Se Chang Kwon
  • Patent number: 12138058
    Abstract: A non-invasive, wearable and portable medical device for evaluation and monitoring the heart condition for patients with congestive heart failure and a CHF management system is provided comprising a wearable textile-based device utilizing physiologic and biometric sensors, a Signal Acquisition Unit, and a monitoring system executing a suite of software algorithms to monitor and evaluate patients with CHF.
    Type: Grant
    Filed: February 11, 2021
    Date of Patent: November 12, 2024
    Assignee: NANOWEAR INC.
    Inventors: Vijay Varadan, Pratyush Rai, Se Chang Oh, Prashanth Shyam Kumar, Mouli Ramasamy
  • Publication number: 20240264744
    Abstract: A memory system includes a memory device including a plurality of memory blocks and a memory controller. The memory controller determines, when a read request for data stored in a first memory block among the plurality of memory blocks is received, whether a dummy read operation on the first memory block is to be performed, based on an erase count value of a second memory block which shares a block word line with the first memory block before a read operation on the first memory block is performed.
    Type: Application
    Filed: August 3, 2023
    Publication date: August 8, 2024
    Applicant: SK hynix Inc.
    Inventor: Se Chang PARK
  • Patent number: 12018060
    Abstract: The present invention relates to a novel peptide of a glucagon derivative and a composition for preventing or treating obesity comprising the peptide as an active ingredient. The glucagon derivative according to the present invention shows a more excellent activating effect with regard to both glucagon-like peptide-1 receptors and glucagon receptors compared to native glucagon, and thus can be widely used as an effective agent for treating obesity.
    Type: Grant
    Filed: October 12, 2021
    Date of Patent: June 25, 2024
    Assignee: Hanmi Pharm Co., Ltd.
    Inventors: Sung Youb Jung, Young Jin Park, Jong Suk Lee, Jae Hyuk Choi, Chang Ki Lim, Se Chang Kwon
  • Publication number: 20240189475
    Abstract: An example embodiment of the present disclosure relates to a nanofiber scaffold including polycaprolactone (poly(?-caprolactone; PCL), decellularized extracellular matrix (dECM) and usnic acid (UA), and a preparation method thereof. The nanofiber scaffold of an example embodiment of the present disclosure has a uniform nanofiber structure, good fluid absorption and retention, moderate release rate, high mechanical stability, thermal stability, and semi-crystalline structure, and exhibits excellent antibacterial efficacy against fungi/bacteria such as Candida albicans, and good compatibility with human-derived fibroblasts.
    Type: Application
    Filed: May 12, 2023
    Publication date: June 13, 2024
    Applicant: PUKYONG NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION
    Inventors: Won-Kyo Jung, Milan Pathum Chandika, Tae-Hee Kim, Se-Chang Kim
  • Patent number: 11872283
    Abstract: The present invention relates to a conjugate comprising oxyntomodulin, an immunoglobulin Fc region, and non-peptidyl polymer wherein the conjugate being obtainable by covalently linking oxyntomodulin to immunoglobulin Fc region via non-peptidyl polymer, and a pharmaceutical composition for the prevention or treatment of obesity comprising the conjugates. The conjugate comprising oxyntomodulin and the immunoglobulin Fc of the present invention reduces food intake, suppresses gastric emptying, and facilitates lipolysis without side-effects, unlike native oxyntomodulin, and also shows excellent receptor-activating effects and long-term sustainability, compared to native oxyntomodulin. Thus, it can be widely used in the treatment of obesity with safety and efficacy.
    Type: Grant
    Filed: July 9, 2019
    Date of Patent: January 16, 2024
    Assignee: Hanmi Science Co., Ltd
    Inventors: Sung Youb Jung, Dae Jin Kim, Sung Hee Park, Young Eun Woo, In Young Choi, Se Chang Kwon
  • Patent number: 11752216
    Abstract: The present invention relates to an insulin analog conjugate and use thereof.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: September 12, 2023
    Assignee: HANMI PHARM. CO., LTD.
    Inventors: Young Jin Park, In Young Choi, Sung Youb Jung, Se Chang Kwon
  • Publication number: 20230220034
    Abstract: A method for improving the solubility of a physiologically active protein or peptide compared to that of a physiologically active protein or peptide which is not conjugated to an immunoglobulin Fc fragment is disclosed. The method includes steps of conjugating the physiologically active protein or peptide to an immunoglobulin Fc fragment. Also disclosed is a composition for improving the solubility of a physiologically active protein or peptide, which contains an immunoglobulin Fc fragment. The composition improves the solubility compared to a composition without an immunoglobulin Fc fragment.
    Type: Application
    Filed: June 13, 2022
    Publication date: July 13, 2023
    Applicant: HANMI PHARM. CO., LTD
    Inventors: Hyung Kyu LIM, Jong Soo LEE, Dae Jin KIM, Sung Min BAE, Sung Youb JUNG, Se Chang KWON
  • Publication number: 20230212103
    Abstract: Polyethylene glycol derivatives of the following formula I and uses thereof are disclosed. A method for manufacturing the polyethylene glycol derivatives is also disclosed.
    Type: Application
    Filed: December 20, 2022
    Publication date: July 6, 2023
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Dae Jin KIM, Jong Soo LEE, SungMin BAE, Se Chang KWON
  • Patent number: 11603346
    Abstract: The present invention relates to polyethylene glycol derivatives and use thereof.
    Type: Grant
    Filed: March 7, 2017
    Date of Patent: March 14, 2023
    Assignee: HANMI PHARM. CO., LTD.
    Inventors: Dae Jin Kim, Jong Soo Lee, Sung Min Bae, Se Chang Kwon
  • Publication number: 20220380437
    Abstract: A physiologically active polypeptide-immunoglobulin Fc fragment conjugate and a method for making the conjugate are disclosed. The conjugate contains a physiologically active polypeptide linked via a non-peptidyl linker to an immunoglobulin Fc fragment having an FcRn-binding region and maintains the intrinsic binding affinity of the immunoglobulin Fc fragment. A method of maintaining the intrinsic binding affinity of the conjugate for FcRn, and a composition containing the conjugate, which maintains the intrinsic binding affinity of the immunoglobulin Fc fragment for FcRn are also disclosed.
    Type: Application
    Filed: August 3, 2022
    Publication date: December 1, 2022
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Sang Youn HWANG, Jong Soo Lee, Sung Hee Hong, In Young Choi, Sung Youb Jung, Se Chang Kwon
  • Patent number: 11494116
    Abstract: There are provided a memory controller and a memory system having the same. The memory controller includes: a central processing unit configured to output a read command for checking an erase state of a selected storage region in response to a program request from a host, determine the number of dummy pages according to the erase state, and output a program command according to the number of dummy pages; and a memory interface configured to, when user data corresponding to the program request is output to the selected storage region, selectively generate dummy data corresponding to the number of dummy pages, and output the dummy data with the user data.
    Type: Grant
    Filed: May 28, 2019
    Date of Patent: November 8, 2022
    Assignee: SK hynix Inc.
    Inventor: Se Chang Park
  • Patent number: 11434271
    Abstract: A method for preparing a conjugate of a physiologically active polypeptide and a non-peptide polymer by linking physiologically active polypeptide with non-peptide polymer through a covalent bond using an organic solvent is provided. A method for preparing a physiologically active polypeptide complex by linking the conjugate with a carrier is provided. The complex shows improved in vivo duration and stability of the physiologically active polypeptide. The method can prepare the conjugate at a lower production cost, and the resulting conjugate shows an extension of in vivo activity at a relatively high level and significantly increase in the blood half-life.
    Type: Grant
    Filed: November 2, 2012
    Date of Patent: September 6, 2022
    Assignee: HANMI SCIENCE CO., LTD.
    Inventors: Dae Jin Kim, Myung Hyun Jang, Seung Su Kim, Jong Soo Lee, Jae Hyuk Choi, Se Chang Kwon
  • Publication number: 20220249615
    Abstract: Provided is a complex composition, of which positional isomers are minimized by using a N-terminus of an immunoglobulin Fc region as a binding site when the immunoglobulin Fc region is used as a carrier. Also provided are a protein complex which is prepared by N-terminal-specific binding of immunoglobulin Fc region, thereby prolonging blood half-life of the physiologically active polypeptide, maintaining in vivo potency at a high level, and having no risk of immune responses, a preparation method thereof, and a pharmaceutical composition including the same for improving in vivo duration and stability of the physiologically active polypeptide. The protein complex may be usefully applied to the development of long-acting formulations of various physiologically active polypeptide drugs.
    Type: Application
    Filed: April 27, 2022
    Publication date: August 11, 2022
    Applicant: HANMI PHARM. CO., LTD
    Inventors: Dae Jin KIM, Jong Soo LEE, Young Jin PARK, Sung Hee HONG, Sung Min BAE, Se Chang KWON